May/June 2026
May/June 2026 | Features
PBM for AMD: Mechanisms, Evidence, and Clinical Integration
Photobiomodulation shows promise, but long-term data are needed.
Luis Acabá-Berrocal, MD, and Anton Orlin, MD
May/June 2026 | Features
Predicting Progression to GA Using Imaging Biomarkers
Several OCT findings can help clinicians better understand a patient’s risk of progression to sight-threatening disease.
Kelly Donovan, MD, PhD, and Eleonora M. Lad, MD, PhD
May/June 2026 | Features
Influence of Mediterranean-Style Diet on AMD
Our findings suggest certain dietary and lifestyle habits may confer long-term protective benefits.
Christopher Phung, BA; Beryl Zhou, BS; Robert Luca, BA; and Dimitra Skondra, MD, PhD
May/June 2026 | Features
Landmark Trials in AMD
A summary of the clinical trials that have shaped—and continue to shape—how we treat AMD.
Saghar Bagheri, MD, PHD; Alberto Quarta, MD; Rouzbeh Abbasgholizadeh, MD; Alessandro Feo, MD; Paolo Forte, MD; David Sarraf, MD; Michael S. Ip, MD; and SriniVas R. Sadda, MD, FARVO
Popular Articles
April 2026 Insert
One to Watch: Samir N. Patel, MD
Samir N. Patel, MD
March 2026 Supplement | Digital Supplement
From Vascular Curiosity to Neurodegenerative Disease: A Consensus Statement for the Diagnosis and Management of Macular Telangiectasia Type 2
Lejla Vajzovic, MD, FASRS; Sophie Bakri, MD; W. Lloyd Clark, MD; Diana Do, MD; Dean Eliott, MD; Roger Goldberg, MD; and Dante Pieramici, MD
May/June 2026 Supplement | Editorial
The Economics Of Care
Alan Ruby, MD
January/February 2026 Supplement
Introducing ENCELTO Into Retina Practices
David Chin Yee, MD, and Jiong Yan, MD